The global antifibrotic drugs market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The key factor that is anticipated to drive the market growth includes the rising prevalence of idiopathic pulmonary fibrosis and the growing R&D activities. Idiopathic pulmonary fibrosis is a serious, though rare disease majorly affecting human lungs. […]
